Open access
Oct 2026
Lymphoma response to chimeric antigen receptor T cell therapy is driven by endogenous tumor-reactive CD8⁺ T cells
B. Ziccheddu, C. Savid-Frontera, V. V. Saralamma et al.
· bioRxiv · 0 citations